35% stock price plummeting deep pit leads to wave of litigation. Hims & Hers (HIMS.US) management accused of misleading investors.

The Zhixun Finance APP has learned that the sudden termination of a brief partnership between Hims & Hers Health (HIMS.US), which focuses on providing remote medical services and personalized health products through an online platform, and the global weight loss drug leader Novo Nordisk (NVO.US) has resulted in increasing legal troubles for investors targeting this remote medical company.